Sarcopenia Treatment Market
Sarcopenia Treatment Market Study by Protein Supplements, Vitamin B12 Supplements, and Vitamin D & Calcium Supplements from 2024 to 2034
Analysis of Sarcopenia Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Sarcopenia Treatment Market Outlook (2024 to 2034)
The global sarcopenia treatment market is estimated to be valued at US$ 3.07 billion in 2024 and further increase at a CAGR of 4.2% to reach US$ 4.63 billion by 2034.
Demand for sarcopenia treatments is increasing as people are becoming conscious about their body strength. People want their bodies to be active even in old age, and they are actively looking for symptoms that may cause diseases such as sarcopenia.
Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Muscle loss can lead to decreased strength, immobility, and, ultimately, adverse health outcomes. Heightened awareness has contributed to the expansion of the sarcopenia treatment market size.
Key Market Growth Drivers
- Primary cause of sarcopenia is the natural aging process. Therefore, suppliers are closely monitoring census data to identify potential buyers and enhance profitability.
- As younger generations become health-conscious, they proactively identify symptoms of sarcopenia and seek appropriate treatments, thus expanding the customer base for sarcopenia drug suppliers.
- Many individuals seek natural treatments, such as consuming fruits and vegetables, along with high-calorie, high-protein diets, to slow down muscle loss.
- Exercise has been proven to be an effective treatment for sarcopenia, often complementing drug therapies to accelerate recovery.
- Various treatment modalities, including nutritional and exercise therapy, are available, with rheumatologists tailoring treatments based on age and immune system status, further driving market growth.
- Treatment providers enhance the effectiveness of medications by incorporating compounds such as myostatin inhibitors, vitamin D, angiotensin, and omega-3 supplements, which facilitate faster strength recovery with minimal side effects, thereby boosting the demand for these treatments.
| Report Attributes | Details |
|---|---|
| Sarcopenia Treatment Market Size (2024E) | US$ 3.07 Billion |
| Forecasted Market Value (2034F) | US$ 4.63 Billion |
| Global Market Growth Rate (2024 to 2034) | 4.2% CAGR |
| Canada Market Growth Rate (2024 to 2034) | 4.3% CAGR |
| Brazil Market Value (2034F) | US$ 72 Million |
| North America Market Share (2024E) | 43.9% |
| Latin America Market Share (2034F) | 2.7% |
| Key Companies Profiled | Bayer AG; Haleon Group of Companies; Zydus Life Sciences Limited; Eli Lilly and Company; Novartis AG; Abbott Laboratories Inc.; GlaxoSmithKline Plc; F-Hoffmann La-Rache; Sanofi Inc.; Amway Corporation |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
How is Research on Sarcopenia and Associated Treatment Modalities Driving Market Growth?
“Increasing Studies Confirming Efficacy of Nutrient Supplementation Paired with Exercise”
Expanding scientific and technological efforts are assisting in determining the protein dose necessary to address the body's protein shortage.
- For instance, a paper published in March 2022 highlighted that protein supplementation combined with exercise improves lower-extremity strength in healthy older individuals with sarcopenia in Asian nations. Research published in PubMed in March 2022 found similar results,
Strategic initiatives by major competitors and increased awareness of the necessity of sarcopenia therapies are projected to drive market expansion during the forecast period.
- For example, World Sarcopenia Day was observed worldwide in July 2022 to increase awareness and information about the common disease sarcopenia.
Therefore, as consumers become more aware of these illnesses, the demand for protein supplements and related goods is projected to increase.
Which Sarcopenia Treatment Market Trends are Proving Beneficial for Market Players?
“Expanding Aging Population and Increased Susceptibility to Sarcopenia”
Increasing elderly population is a significant factor driving the growth of the sarcopenia treatment market due to the prevalence of sarcopenia among older individuals. The global population also is projected to continue growing, with people over 65 being one of the fastest-growing age groups worldwide.
- According to the National Institutes of Health (NIH), the global population aged 80 and above is projected to rise from 126.5 million to 446.6 million between 2015 and 2050.
Increased out-of-pocket healthcare spending is also forecast to contribute to the growing demand for sarcopenia therapy supplements.
- According to the National Health Expenditure Account (NHEA), U.S. healthcare spending rose by 4.3% percent in 2016, reaching US$ 3.3 trillion or US$ 10,348.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What Challenges Do Healthcare Practitioners Face in Diagnosing and Treating Sarcopenia?
“Lack of Standardized Diagnostic Criteria and Limited Testing Frequency”
Healthcare practitioners may not frequently test for sarcopenia, particularly in adults, limiting early intervention and treatment commencement. Without a defined diagnosis, healthcare professionals may utilize a variety of criteria and procedures to detect sarcopenia. This mismatch may result in differences in the reported prevalence of sarcopenia and the number of diagnosed cases, making it difficult to determine the real market size and demand for treatments.
Sarcopenia is a complicated disorder that affects people differently according to age, gender, and comorbidities. Patient groups may be varied, making it difficult to perform clinical trials and research to reliably evaluate therapy efficacy without defined diagnostic criteria.
Clinical trials for sarcopenia therapies may employ varied diagnostic criteria, making it difficult to compare the findings of many research studies. The absence of uniformity can impede the development and approval of innovative medicines by regulatory bodies.
Country-wise Evaluation
According to an unveiled report from Fact.MR, a leading market research company, the North American region is forecast to occupy a leading sarcopenia treatment market share due to the increasing prevalence of sarcopenia among the aging population in the United States, Canada, and Mexico. The Mexico market is projected to expand at a CAGR of 4.4% from 2024 to 2034.
What Opportunities are Market Players Exploiting in the United States?
“High Health Awareness Among Public and Healthcare Providers Leading to Early Sarcopenia Diagnosis”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 1.24 Billion |
| Growth Rate (2024 to 2034) | 4.6% CAGR |
| Projected Value (2034F) | US$ 1.95 Billion |
Sarcopenia is commonly linked with chronic conditions such as diabetes, cancer, and cardiovascular diseases. The growing incidence of these ailments contributes to the rising prevalence of sarcopenia in the United States, driving up the demand for treatments. This surge in cases has spurred consumers to seek therapies, thereby supporting sarcopenia treatment market growth.
Increased awareness among both the public and medical professionals in the country is leading to timely diagnosis of sarcopenia. As awareness expands, there is a growing demand for effective medications and interventions. These factors have incentivized market players to expand their businesses to capitalize on market opportunities.
Why are Sarcopenia Treatment Providers Investing in Brazil?
“Increased Prevalence of Sarcopenia Due to Low Consumption of Micronutrient-Rich Foods”
| Attribute | Brazil |
|---|---|
| Market Value (2024E) | US$ 53 Million |
| Growth Rate (2024 to 2034) | 3.1% CAGR |
| Projected Value (2034F) | US$ 72 Million |
Micronutrient-rich foods are consumed in low quantities in developing nations like Brazil, leading to malnutrition. Sarcopenia is primarily caused by malnutrition, which is widespread in Latin America, Africa, and Southeast Asia due to poor nutritional conditions.
Rising prevalence of malnutrition leads to an increase in sarcopenia cases, resulting in a significant demand for sarcopenia therapy supplements. Vitamin D and B12 deficiencies are common among vegetarians and the elderly, serving as primary causes of sarcopenia.
The growing insufficiency of vitamins is expected to fuel the demand for sarcopenia treatment supplements. As a result, Brazil has become a lucrative market for providers to capitalize on and generate substantial profits.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Retail pharmacies are projected to account for a significant market share by 2034, and this segment is forecasted to expand at a CAGR of 13.6% from 2024 to 2034.
How are Protein Supplements Aiding in Sarcopenia Treatment?
“Vital Role of Protein Supplements in Building Muscle and Boosting Metabolism”
| Attribute | Protein Supplements |
|---|---|
| Segment Value (2024E) | US$ 2.68 Billion |
| Growth Rate (2024 to 2034) | 4.2% CAGR |
| Projected Value (2034F) | US$ 4.06 Billion |
Protein supplements are known for building muscles, aiding weight loss, promoting better recovery, and boosting metabolism. These attributes have prompted many people to incorporate protein supplements into their routine to regain energy. Suppliers in the market have begun ramping up the production of such supplements to seize this profitable opportunity, establish dominance, and potentially create a monopoly in the market.
Which Distribution Channel is Primarily Used by Treatment Providers in the Market?
“Hypermarkets and Supermarkets Occupying Leading Market Share”
| Attribute | Hypermarkets & Supermarkets |
|---|---|
| Segment Value (2024E) | US$ 917.2 Million |
| Growth Rate (2024 to 2034) | 15.6% CAGR |
| Projected Value (2034F) | US$ 3.91 Billion |
Hypermarkets and supermarkets have direct contact with suppliers thus they can manage to sell products at much lower prices. People always look for such low-price areas to buy quality products at much cheaper rates, thus improving the sales in the market.
Business Rivalry
Key players in the sarcopenia treatment industry are employing various strategies to enhance product penetration. Leading manufacturers in the market are focusing on innovative marketing and sales methods. Companies selling sarcopenia therapy supplements are prioritizing online product offerings and digital marketing.
- Metagenics LLC acquired 100% of Amipro Advanced Development Products in October 2023. For many years, Ampiro was the exclusive distributor of Metagenics LLC's goods in South Africa. The acquisition has enhanced Metagenics’ distribution network in the nation, allowing it to conduct direct distribution operations in all key EMEA markets.
- Biophytis was granted permission by the United States Food and Drug Administration (FDA) in September 2023 to begin its SARA-31 research in the United States. This is the first phase 3 trial in the sarcopenia therapy field.
Key Segments of Sarcopenia Treatment Market Research
-
By Product Type :
- Protein Supplements
- Vitamin B12 Supplements
- Vitamin D & Calcium Supplements
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Hypermarkets & Supermarkets
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Global Market Volume (Units) Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 7. Global Market - Pricing Analysis
- 8. Global Market Value Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Product Type
- 9.1. Protein Supplements
- 9.2. Vitamin B12 Supplements
- 9.3. Vitamin D & Calcium Supplements
- 10. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Distribution Channel
- 10.1. Hospital Pharmacies
- 10.2. Retail Pharmacies
- 10.3. Online Pharmacies
- 10.4. Hypermarkets & Supermarkets
- 11. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Europe
- 11.4. East Asia
- 11.5. South Asia
- 11.6. Oceania
- 11.7. Middle East and Africa (MEA)
- 12. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 13. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 14. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 15. South Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 16. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 17. Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 18. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 19. Key and Emerging Countries Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. Bayer AG
- 21.2. Haleon Group of Companies
- 21.3. Zydus Life Sciences Limited
- 21.4. Eli Lilly and Company
- 21.5. Novartis AG
- 21.6. Abbott Laboratories Inc.
- 21.7. GlaxoSmithKline Plc
- 21.8. F-Hoffmann La-Rache
- 21.9. Sanofi Inc.
- 21.10. Amway Corporation
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
Table 08: Latin America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
Table 11: Europe Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
Table 14: South Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
Table 17: East Asia Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
Table 20: Oceania Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Product Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018 to 2034, By Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2018 to 2023
Figure 02: Global Market Volume Forecast (in 000' Units), 2024 to 2034
Figure 03: Pricing Analysis (US$) Per Product Type, By Region, 2023
Figure 04: Pricing Analysis (US$) Per Product Type, By Region, 2023
Figure 05: Global Market Value Analysis (US$ Mn), 2018 to 2023
Figure 06: Global Market Value Forecast (US$ Mn), 2024 to 2034
Figure 07: Global Market Absolute $ Opportunity, 2024 to 2034
Figure 08: Global Market Share Analysis (%), By Product Type, 2024 to 2034
Figure 09: Global Market Y-o-Y Analysis (%), By Product Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 11: Global Market Share Analysis (%), By Distribution Channel , 2024 to 2034
Figure 12: Global Market Y-o-Y Analysis (%), By Distribution Channel , 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Distribution Channel , 2024 to 2034
Figure 14: Global Market Share Analysis (%), By Region, 2024 to 2034
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value Share, By Product Type, 2024 (E)
Figure 18: North America Market Value Share, By Distribution Channel , 2024 (E)
Figure 19: North America Market Value Share, By Country, 2024 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 21: North America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 22: North America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Distribution Channel , 2024 to 2034
Figure 24: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 25: Latin America Market Value Share, By Product Type, 2024 (E)
Figure 26: Latin America Market Value Share, By Distribution Channel , 2024 (E)
Figure 27: Latin America Market Value Share, By Country, 2024 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2018 to 2023
Figure 29: Latin America Market Value Forecast (US$ Mn), 2024 to 2034
Figure 30: Latin America Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 31: Latin America Market Attractiveness Analysis by Distribution Channel , 2024 to 2034
Figure 32: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 33: Europe Market Value Share, By Product Type, 2024 (E)
Figure 34: Europe Market Value Share, By Distribution Channel , 2024 (E)
Figure 35: Europe Market Value Share, By Country, 2024 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2018 to 2023
Figure 37: Europe Market Value Forecast (US$ Mn), 2024 to 2034
Figure 38: Europe Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 39: Europe Market Attractiveness Analysis by Distribution Channel , 2024 to 2034
Figure 40: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 41: South Asia Market Value Share, By Product Type, 2024 (E)
Figure 42: South Asia Market Value Share, By Distribution Channel , 2024 (E)
Figure 43: South Asia Market Value Share, By Country, 2024 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 45: South Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 46: South Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 47: South Asia Market Attractiveness Analysis by Distribution Channel , 2024 to 2034
Figure 48: South Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 49: East Asia Market Value Share, By Product Type, 2024 (E)
Figure 50: East Asia Market Value Share, By Distribution Channel , 2024 (E)
Figure 51: East Asia Market Value Share, By Country, 2024 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2018 to 2023
Figure 53: East Asia Market Value Forecast (US$ Mn), 2024 to 2034
Figure 54: East Asia Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 55: East Asia Market Attractiveness Analysis by Distribution Channel , 2024 to 2034
Figure 56: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 57: Oceania Market Value Share, By Product Type, 2024 (E)
Figure 58: Oceania Market Value Share, By Distribution Channel , 2024 (E)
Figure 59: Oceania Market Value Share, By Country, 2024 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2018 to 2023
Figure 61: Oceania Market Value Forecast (US$ Mn), 2024 to 2034
Figure 62: Oceania Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 63: Oceania Market Attractiveness Analysis by Distribution Channel , 2024 to 2034
Figure 64: Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 65: Middle East and Africa Market Value Share, By Product Type, 2024 (E)
Figure 66: Middle East and Africa Market Value Share, By Distribution Channel , 2024 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2024 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2018 to 2023
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2024 to 2034
Figure 70: Middle East and Africa Market Attractiveness Analysis by Product Type, 2024 to 2034
Figure 71: Middle East and Africa Market Attractiveness Analysis by Distribution Channel , 2024 to 2034
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2024 to 2034
Figure 73: UNITED STATES Market Value Analysis (US$ Mn), 2024 & 2034
Figure 74: UNITED STATES Market Value Share, By Product Type, 2024 (E)
Figure 75: UNITED STATES Market Value Share, By Distribution Channel , 2024 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2024 & 2034
Figure 77: Canada Market Value Share, By Product Type, 2024 (E)
Figure 78: Canada Market Value Share, By Distribution Channel , 2024 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2024 & 2034
Figure 80: Mexico Market Value Share, By Product Type, 2024 (E)
Figure 81: Mexico Market Value Share, By Distribution Channel , 2024 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2024 & 2034
Figure 83: Brazil Market Value Share, By Product Type, 2024 (E)
Figure 84: Brazil Market Value Share, By Distribution Channel , 2024 (E)
Figure 85: UNITED KINGDOM Market Value Analysis (US$ Mn), 2024 & 2034
Figure 86: UNITED KINGDOM Market Value Share, By Product Type, 2024 (E)
Figure 87: UNITED KINGDOM Market Value Share, By Distribution Channel , 2024 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2024 & 2034
Figure 89: Germany Market Value Share, By Product Type, 2024 (E)
Figure 90: Germany Market Value Share, By Distribution Channel , 2024 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2024 & 2034
Figure 92: France Market Value Share, By Product Type, 2024 (E)
Figure 93: France Market Value Share, By Distribution Channel , 2024 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2024 & 2034
Figure 95: Italy Market Value Share, By Product Type, 2024 (E)
Figure 96: Italy Market Value Share, By Distribution Channel , 2024 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2024 & 2034
Figure 98: Spain Market Value Share, By Product Type, 2024 (E)
Figure 99: Spain Market Value Share, By Distribution Channel , 2024 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 101: Russia Market Value Share, By Product Type, 2024 (E)
Figure 102: Russia Market Value Share, By Distribution Channel , 2024 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2024 & 2034
Figure 104: China Market Value Share, By Product Type, 2024 (E)
Figure 105: China Market Value Share, By Distribution Channel , 2024 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2024 & 2034
Figure 107: Japan Market Value Share, By Product Type, 2024 (E)
Figure 108: Japan Market Value Share, By Distribution Channel , 2024 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2024 & 2034
Figure 110: South Korea Market Value Share, By Product Type, 2024 (E)
Figure 111: South Korea Market Value Share, By Distribution Channel , 2024 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2024 & 2034
Figure 113: India Market Value Share, By Product Type, 2024 (E)
Figure 114: India Market Value Share, By Distribution Channel , 2024 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2024 & 2034
Figure 116: ASEAN Market Value Share, By Product Type, 2024 (E)
Figure 117: ASEAN Market Value Share, By Distribution Channel , 2024 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 119: Australia Market Value Share, By Product Type, 2024 (E)
Figure 120: Australia Market Value Share, By Distribution Channel , 2024 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2024 & 2034
Figure 122: New Zealand Market Value Share, By Product Type, 2024 (E)
Figure 123: New Zealand Market Value Share, By Distribution Channel , 2024 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2024 & 2034
Figure 125: GCC Countries Market Value Share, By Product Type, 2024 (E)
Figure 126: GCC Countries Market Value Share, By Distribution Channel , 2024 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2024 & 2034
Figure 128: Turkey Market Value Share, By Product Type, 2024 (E)
Figure 129: Turkey Market Value Share, By Distribution Channel , 2024 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2024 & 2034
Figure 131: South Africa Market Value Share, By Product Type, 2024 (E)
Figure 132: South Africa Market Value Share, By Distribution Channel , 2024 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the sarcopenia treatment market size in 2024?
The global market for sarcopenia treatment stands at US$ 3.07 billion in 2024.
What is the projected revenue from sarcopenia treatment for 2034?
By 2034, worldwide revenue from sarcopenia treatment is projected to reach US$ 4.63 billion.
How fast are sarcopenia drug sales projected to increase?
Sarcopenia drug sales are forecasted to increase at 4.2% CAGR through 2034.
What is the sales forecast for sarcopenia treatment in North America?
The market in North America are forecasted to increase at 4.6% CAGR from 2024 to 2034.
At what rate is the market projected to expand in Latin America?
The market in Latin America is projected to expand at a CAGR of 3% from 2024 to 2034.
What are the forecasts for the market in Chile?
The market in Chile has been forecasted to rise at a CAGR of 3% from 2024 to 2034.
Sarcopenia Treatment Market